QUOTIENT SCIENCES
Quotient Sciences provides formulation development, clinical pharmacology, clinical & commercial manufacturing services.
QUOTIENT SCIENCES
Industry:
Clinical Trials Health Care Manufacturing Medical Pharmaceutical
Founded:
2004-01-01
Address:
Nottingham, Nottingham, United Kingdom
Country:
United Kingdom
Website Url:
http://www.quotientsciences.com
Total Employee:
251+
Status:
Active
Contact:
800- 769-3518
Email Addresses:
[email protected]
Total Funding:
35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Nginx Sitelinks Search Box Organization Schema IPv6
Similar Organizations
ConvaTec
ConvaTec specializes in the development, manufacture, distribution of single-use devices to hospitals and healthcare sectors.
Sovereign Pharmaceuticals
Sovereign Pharmaceuticals offers formulation development, regulatory and clinical affairs, quality management, and manufacturing services.
Current Employees Featured
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-02-09 | Arcinova | Arcinova acquired by Quotient Sciences | N/A |
| 2017-11-14 | Pharmaterials | Pharmaterials acquired by Quotient Sciences | N/A |
| 2017-02-14 | QS Pharma | QS Pharma acquired by Quotient Sciences | N/A |
| 2017-02-06 | SeaView Research | SeaView Research acquired by Quotient Sciences | N/A |
Investors List
TA Associates
TA Associates investment in Private Equity Round - Quotient Sciences
Newest Events participated
Participated in Early Clinical Development 2017
on 2017-11-28 as exhibitor
Participated in 7th American Drug Delivery and Formulation Summit 2017
on 2017-08-28 as sponsor
Official Site Inspections
http://www.quotientsciences.com Semrush global rank: 1.42 M Semrush visits lastest month: 19.79 K
- Host name: ec2-18-134-108-134.eu-west-2.compute.amazonaws.com
- IP address: 18.134.108.134
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Quotient Sciences"
About Us | What We Do | Quotient Sciences
Quotient Sciences has worked with customers as a trusted partner, providing contract research and manufacturing expertise across all stages of small molecule and synthetic peptide drug development for the last 30 years.See details»
At A Glance | About Us | Quotient Sciences
Quotient Sciences is a drug development and manufacturing accelerator supporting customers across the entire development pathway from candidate selection to commercial launch.See details»
Quotient Sciences - Crunchbase Company Profile & Funding
Quotient Sciences provides formulation development, clinical pharmacology, clinical & commercial manufacturing services.See details»
Quotient Sciences - Craft
Quotient Sciences is a contract development and manufacturing organization. It provides formulation development, clinical pharmacology trials, clinical and commercial manufacturing …See details»
About QUOTIENT SCIENCES LIMITED. - CPHI Online
Collaboration Expedites Human Clinical Trials for COVID-19 Drug Candidate. A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials was announced today [April 28, 2020] by Quotient …See details»
Interview with Thierry Van Nieuwenhove: On Quotient Sciences' …
In this interview with Thierry Van Nieuwenhove, Quotient Sciences' Chief Executive Officer, we delve into the unique factors that set the company apart, the strategic growth plans aimed at …See details»
Quotient Sciences - Drug Development and Delivery
Dec 1, 2023 DRUG DEVELOPMENT & DELIVERY 170 Changebridge Road Suite C5-4 Montville, NJ 07045 Tel: (973) 299-1200 Fax: (973) 299-7937See details»
Dr. Andrew Lewis - Chief Scientific Officer | Quotient Sciences
Dr. Andrew (Andy) Lewis is the Chief Scientific Officer at Quotient Sciences. As the leader of Quotient Sciences' scientific teams and drug development consultants, Andy is responsible for …See details»
More than a CRO | Quotient Sciences
Quotient Sciences is more than a global contract research organization (CRO). We deliver clinical expertise, integrated and tailored for your drug product's success.See details»
Quotient Sciences - VentureRadar
Mar 22, 2019 Syngene (Biocon) India n/a Syngene is an innovation-led contract research, development, and manufacturing organization offering integrated scientific services from early …See details»
Quotient Sciences Company Profile | Management and Employees …
SQL International Organization for Standardization . PHP PHP . HTML Web Hypertext Application Technology Working Group . CSS World Wide Web Consortium . Business Intelligence ...See details»
Quotient Sciences - Permira
Building a best-in-class pharmaceutical services business, Quotient Sciences takes an innovative approach to drug development. Through its unique Translational Pharmaceutics platform, …See details»
QUOTIENT SCIENCES COMPLETES INTEGRATION OF DRUG …
Feb 17, 2022 Quotient Sciences Translational Pharmaceutics ® approach – combining manufacturing and clinical dosing at a single organization – enables innovators to adjust …See details»
Careers - Quotient Sciences
We are proud of our people, and the difference they make to humanity. We encourage innovation and continuous improvement. Are you looking for a rewarding career?See details»
Information sheet Aseptic Development and Manufacturing
Quotientsciences.com Parenteral drug products, also known as injectables, are a rapidly growing area in the pharmaceutical market. Injectables ... International Organization for …See details»
Services | What We Do | Quotient Sciences
We offer the choice of integrated drug development programs or tailored individual drug development services and solutions that help customers accelerate their drug development …See details»
Information sheet Peptide Development Strategies
At one organization. When integrated, these services offer a single supply chain, led by a single project manager, under a ... Email [email protected] Visit …See details»
Quotient Sciences Announces Significant Growth in Workforce at …
NOTTINGHAM, UK; March 28, 2023 – Quotient Sciences, the drug development and manufacturing accelerator, today announced that it has grown the workforce at its Alnwick, …See details»
Spotlight on Data Sciences at Quotient Sciences
Data Sciences are a critical part of drug development. During clinical research studies, a significant amount of data is generated, which needs to be carefully processed, analyzed, …See details»